#VELA investee co. #ENSI Ensilica PLC – EnSilica joins TSMC Design Center Alliance September 19, 2024 – Posted in: Vela Technologies Plc (VELA)

EnSilica, a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), is pleased to announce that it has joined the Design Center Alliance (“DCA”) of the Taiwan Semiconductor Manufacturing Company’s (“TSMC”) Open Innovation Platform® (“OIP”). TSMC’s DCA programme focuses on chip implementation service and system level design solution enablement to lower the design barriers for customers adopting TSMC technology. EnSilica’s partnership with TSMC through the DCA programme strengthens EnSilica’s value in enabling the…

#POLB Poolbeg Pharma PLC – Annual Report & AGM Notice May 9, 2024 – Posted in: Poolbeg Pharma (POLB)

9 May 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, confirms that the Company’s Annual Report and Accounts for the period ended 31 December 2023 and the notice of Annual General Meeting (“AGM”) will be posted to shareholders today. The 2023 Annual Report and Accounts, the Notice of AGM and accompanying form of…

#POLB Poolbeg Pharma PLC – RSV AI Drug Candidate Analysis Update December 20, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces the positive outputs from the lab-based analysis and successful prioritisation of the Respiratory Syncytial Virus (‘RSV’) drug targets and treatments identified as part of its artificial intelligence (‘AI’) led programme. Poolbeg’s team of scientific experts have reviewed the comprehensive data package obtained from this lab-based…

#POLB Poolbeg Pharma PLC – Directorate Change November 30, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

30 November 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces a change to its Board of Directors. Patrick Ashe, Independent Non-Executive Director, will step down from the Board at the end of November. Eddie Gibson, Non-Executive Director will replace Patrick as Chair of the Audit & Risk Committee and Prof Brendan Buckley, Non-Executive Director…

#VELA investee co. #ENET Ethernity Networks LTD – Update re. Subscription agreement & Notice of GM November 10, 2023 – Posted in: Vela Technologies Plc (VELA)

Update Regarding Subscription Agreement and TVR Notice of General Meeting Ethernity Networks Ltd (AIM: ENET; OTCMKTS: ENETF), a leading supplier of networking processing semiconductor technology ported on field programmable gate arrays for virtualised networking appliances, announces the following update on the share subscription agreement with 5G Innovation Leaders Fund LLC (the “Subscriber”), details of which were announced on 25 February 2022 (the “Subscription Agreement”). On 24 October 2023, the Company announced that…

#VELA investee co. #ENSI Ensilica PLC – US$7m e-mobility sensor ASIC supply contract win September 13, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

EnSilica, a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), is pleased to announce that it has been awarded an ASIC supply contract for a sensor ASIC to address the e-mobility market (the “Contract“). The Contract is for the design and supply of a mixed signal sensor ASIC for the e-mobility market encompassing electric vehicles (EVs), electric two wheelers, e-bikes, and e-scooters. Based on the volume commitments by the customer, the Contract…

#VELA Vela Technologies – Investee Company #MODE Mode Global Holdings – Mode appoints Dr Jose Sanchez Loureda as CTO July 7, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Mode Global Holdings PLC (LSE: MODE), the LSE-listed Fintech Group, announces the appointment of Dr Jose Sanchez Loureda as Chief Technology Officer. An experienced leader in technology, data analytics and digital transformation, Dr Sanchez Loureda joins the firm following his tenure at The Crown Estate. He will be responsible for helping Mode enhance its tech offering, notably driving product innovation, and understanding customer and merchant needs via data-driven insights. Dr Sanchez Loureda’s experience includes senior…

#VELA investee co. #ENSI Ensilica PLC – EnSilica joins TSMC Design Center Alliance September 19, 2024 – Posted in: Vela Technologies Plc (VELA)

#POLB Poolbeg Pharma PLC – Annual Report & AGM Notice May 9, 2024 – Posted in: Poolbeg Pharma (POLB)

#POLB Poolbeg Pharma PLC – RSV AI Drug Candidate Analysis Update December 20, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

#POLB Poolbeg Pharma PLC – Directorate Change November 30, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

#VELA investee co. #ENET Ethernity Networks LTD – Update re. Subscription agreement & Notice of GM November 10, 2023 – Posted in: Vela Technologies Plc (VELA)

#VELA investee co. #ENSI Ensilica PLC – US$7m e-mobility sensor ASIC supply contract win September 13, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

#VELA Vela Technologies – Investee Company #MODE Mode Global Holdings – Mode appoints Dr Jose Sanchez Loureda as CTO July 7, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Address

Contact

Social

LEGAL